US Patent Issued to Qingdao Haiji Biomedicine, MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO on July 22 for "Use of tegaserod in preparation of anti-tumor drug" (Chinese Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,682, issued on July 22, was assigned to Qingdao Haiji Biomedicine Co. Ltd. (Shandong, China) and MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO Co. LTD. (Shandong, China).

"Use of tegaserod in preparation of anti-tumor drug" was invented by Jinbo Yang (Shandong, China), Qiaoling Song (Shandong, China), Chenyang Zhao (Shandong, China), Lijuan Wu (Shandong, China), Jun Zhao (Shandong, China), Dan Yao (Shandong, China), Yu Tang (Shandong, China), Ximing Xu (Shandong, China) and Menglin Yang (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof...